521 related articles for article (PubMed ID: 16456578)
1. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
2. Brain tumor stem cells as research and treatment targets.
Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
[TBL] [Abstract][Full Text] [Related]
3. Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice.
Arab S; Rutka J; Lingwood C
Oncol Res; 1999; 11(1):33-9. PubMed ID: 10451029
[TBL] [Abstract][Full Text] [Related]
4. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
[TBL] [Abstract][Full Text] [Related]
5. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
Kang MK; Kang SK
Biochem Biophys Res Commun; 2008 Sep; 373(4):539-44. PubMed ID: 18590702
[TBL] [Abstract][Full Text] [Related]
7. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133
Yang L; Li N; Yan Z; Li C; Zhao Z
J Mol Neurosci; 2018 Nov; 66(3):369-377. PubMed ID: 30267383
[TBL] [Abstract][Full Text] [Related]
8. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
[TBL] [Abstract][Full Text] [Related]
10. β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.
Zhu T; Xu Y; Dong B; Zhang J; Wei Z; Xu Y; Yao Y
Oncol Rep; 2011 Aug; 26(2):405-13. PubMed ID: 21519795
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma.
Friesen C; Hormann I; Roscher M; Fichtner I; Alt A; Hilger R; Debatin KM; Miltner E
Cell Cycle; 2014; 13(10):1560-70. PubMed ID: 24626197
[TBL] [Abstract][Full Text] [Related]
12. Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.
Vizirianakis IS; Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Tsiftsoglou AS
J Med Chem; 2010 Oct; 53(19):6779-810. PubMed ID: 20925433
[No Abstract] [Full Text] [Related]
13. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench.
Burkhardt JK; Hofstetter CP; Santillan A; Shin BJ; Foley CP; Ballon DJ; Pierre Gobin Y; Boockvar JA
J Clin Neurosci; 2012 Nov; 19(11):1568-72. PubMed ID: 22985932
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal differentiation of glioblastoma stem cells.
Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
[TBL] [Abstract][Full Text] [Related]
20. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
Skipper HE; Simpson-Herren L
Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
